SVP Clinical Development Jeffrey Wiezorek sold $397K of Kite Pharma, Inc.

Sold$396,652

$44.07Price

9,000Shares

−40%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Tue, Feb 16. Filed Thu, Feb 18, 3:34 PM ET, during the session. Not investment advice.